Tenderwize
Back to tender search

Discount Agreements Dolutegravir and Rilpivirin

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Jun 03, 2028 · 656 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Dolutegravir und Rilpivirin, ATC J05AR21

60/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

60 / 100

Complexity

40 / 100

Risk factors

Open-house model is not subject to procurement law; limited legal remedies via social courts.

No minimum or maximum volume guaranteed; contracts can be terminated with one month's notice.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jul 2028
  • Provision of pharmaceutical products containing Dolutegravir and Rilpivirin
  • Entering non-exclusive discount agreements with AOK Bayern
Show full summary

This is an open-house model (not a formal tender) by AOK Bayern for non-exclusive discount agreements on Dolutegravir and Rilpivirin (ATC J05AR21). All eligible pharmaceutical companies can join at any time until 03.06.2028. Contracts run from 01.08.2026 to 31.07.2028. No estimated value is provided. Eligibility requires a signed declaration of reliability. Submission can be in paper (two originals) or electronic with qualified electronic signature. The notice explicitly states this is not subject to procurement law.

Risks

Open-house model is not subject to procurement law; limited legal remedies via social courts.

No minimum or maximum volume guaranteed; contracts can be terminated with one month's notice.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Contract duration: 01.08.2026 – 31.07.2028

Eligibility

  • Open-house model – no competition, all eligible companies can join

Administrative

  • Rolling admission: submit by 3rd of month for start next month

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria – all eligible participants are accepted.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Discount Agreements Dolutegravir and Rilpivirin

Non-exclusive open-house discount agreements for pharmaceutical products with active substances Dolutegravir and Rilpivirin (ATC J05AR21). Contracts are identical for all participants.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Jul 2026 - Jul 2028

Category

Pharmaceutical products

Award Criteria

No award criteria – all eligible participants are accepted.

Deadline

Deadline Jun 03, 2028

Procurement Details

Publication date
14 Jun 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
407096-2026

Documents (2)

Similar tenders